PubRank
Search
About
Clinical Trial to Assess the Effect of Testosterone in Patients With Poor Ovarian Response (TESTOPRIM) (TESTOPRIM)
Clinical Trial ID NCT03378713
PubWeight™ 0.00
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT03378713
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria.
Hum Reprod
2011
5.49
2
Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles.
Hum Reprod
2011
2.10
3
Androgens stimulate early stages of follicular growth in the primate ovary.
J Clin Invest
1998
2.00
4
Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development.
J Clin Endocrinol Metab
1999
1.74
5
Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique--a prospective, randomized, double-blind study.
Hum Reprod
2006
1.60
6
Clinical management of low ovarian response to stimulation for IVF: a systematic review.
Hum Reprod Update
2003
1.59
7
Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function.
Mol Endocrinol
2010
1.57
8
The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders.
Fertil Steril
2011
1.57
9
The impact of ovarian stimulation on implantation and fetal development in mice.
Hum Reprod
2001
1.52
10
How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis.
Fertil Steril
2008
1.48
11
In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA.
Mol Hum Reprod
2010
1.45
12
Interventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF).
Cochrane Database Syst Rev
2010
1.29
13
The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis.
Hum Reprod Update
2012
1.13
14
Superovulation of female mice delays embryonic and fetal development.
Hum Reprod
2001
1.11
15
Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial.
Hum Reprod
2008
1.00
16
Coordination of early antral follicles by luteal estradiol administration provides a basis for alternative controlled ovarian hyperstimulation regimens.
Fertil Steril
2003
0.96
17
Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH.
Hum Reprod
2006
0.91
18
Role of androgens in normal and pathological ovarian function.
Reproduction
2014
0.91
19
Ovarian Features after 2 Weeks, 3 Weeks and 4 Weeks Transdermal Testosterone Gel Treatment and Their Associated Effect on IVF Outcomes in Poor Responders.
Balsaenggwa Saengsig
2014
0.79
20
Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles.
Fertil Steril
2015
0.79
21
Effective treatment protocol for poor ovarian response: A systematic review and meta-analysis.
J Hum Reprod Sci
2016
0.77
22
Transdermal testosterone pretreatment in poor responders undergoing ICSI: a randomized clinical trial.
Hum Reprod
2016
0.75
23
Antral Follicle Priming Before Intracytoplasmic Sperm Injection in Previously Diagnosed Low Responders: A Randomized Controlled Trial (FOLLPRIM).
J Clin Endocrinol Metab
2015
0.75
24
A randomized, single-blind, prospective trial comparing three different gonadotropin doses with or without addition of letrozole during ovulation stimulation in patients with poor ovarian response.
Eur J Obstet Gynecol Reprod Biol
2016
0.75
25
Pharmacokinetics of a transdermal testosterone cream in healthy postmenopausal women.
Menopause
2015
0.75
26
Assisted conception following poor ovarian response to gonadotrophin stimulation.
Br J Obstet Gynaecol
1997
0.75
Next 100